中国心血管疾病的流行病学现状及改善机遇：《美国心脏病学会杂志：国际版》
Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International.
机构信息
Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Heart Health Research Center, Beijing, China; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
出版信息
J Am Coll Cardiol. 2019 Jun 25;73(24):3135-3147. doi: 10.1016/j.jacc.2019.04.036.
The burden of cardiovascular (CV) disease is very high in China, due to highly prevalent and poorly controlled risk factors resulting from changing sociodemographic structure and lifestyles in its large population. Rapid economic development and urbanization have been accompanied by changing patterns, expression, and management of CV disease. However, the health care system in China lacks a hierarchical structure, with a focus on treating acute diseases in hospital while ignoring long-term management, and primary health care is too weak to effectively control CV risk factors. To address these challenges, the Chinese central government has ensured health is a national priority and has introduced reforms that include implementing policies for a healthy environment, strengthening primary care, and improving affordability and accessibility within the health system. Turning the inverted pyramid of the health care system is essential in the ongoing battle against CV disease.
中国心血管疾病负担很重，这是由于其庞大的人口中普遍存在且控制不佳的风险因素，这些因素是由社会人口结构和生活方式的变化引起的。快速的经济发展和城市化带来了心血管疾病模式、表现和管理的变化。然而，中国的医疗保健系统缺乏层次结构，侧重于在医院治疗急性疾病，而忽视了长期管理，基层医疗保健太薄弱，无法有效控制心血管危险因素。为了解决这些挑战，中国中央政府已将卫生保健作为国家重点，并进行了改革，包括实施健康环境政策、加强基层医疗保健以及改善卫生系统的负担能力和可及性。在与心血管疾病的持续斗争中，必须扭转医疗保健系统的倒金字塔结构。
Zotero 插件